These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 19260132

  • 1. Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach.
    Tirelli G, Biasotto M, Chiandussi S, Dore F, De Nardi E, Di Lenarda R.
    Head Neck; 2009 Sep; 31(9):1249-54. PubMed ID: 19260132
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
    Brown JJ, Ramalingam L, Zacharin MR.
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
    García Sáenz JA, López Tarruella S, García Paredes B, Rodríguez Lajusticia L, Villalobos L, Díaz Rubio E.
    Med Oral Patol Oral Cir Bucal; 2007 Sep 01; 12(5):E351-6. PubMed ID: 17767097
    [Abstract] [Full Text] [Related]

  • 6. [Bisphosphonates and osteonecrosis of the jaws].
    Urade M.
    Clin Calcium; 2007 Feb 01; 17(2):241-8. PubMed ID: 17272882
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE, Umland EM.
    Pharmacotherapy; 2008 May 01; 28(5):667-77. PubMed ID: 18447663
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Orofacial pain - a presenting symptom of bisphosphonate associated osteonecrosis of the jaws.
    Srinivasan D, Shetty S, Ashworth D, Grew N, Millar B.
    Br Dent J; 2007 Jul 28; 203(2):91-2. PubMed ID: 17660779
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis.
    Agrillo A, Ungari C, Filiaci F, Priore P, Iannetti G.
    J Craniofac Surg; 2007 Sep 28; 18(5):1071-5. PubMed ID: 17912085
    [Abstract] [Full Text] [Related]

  • 14. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
    Diego R, D'Orto O, Pagani D, Agazzi A, Marzano U, Derada Troletti G, Fontanella W, Pignataro L.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar 28; 103(3):e1-5. PubMed ID: 17197204
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C, Al-Nawas B, Grötz KA, Thomas C, Thüroff JW, Zinser V, Gamm H, Beck J, Wagner W.
    Eur Urol; 2008 Nov 28; 54(5):1066-72. PubMed ID: 18602738
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review.
    Hewitt C, Farah CS.
    J Oral Pathol Med; 2007 Jul 28; 36(6):319-28. PubMed ID: 17559492
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
    Estilo CL, Van Poznak CH, Wiliams T, Bohle GC, Lwin PT, Zhou Q, Riedel ER, Carlson DL, Schoder H, Farooki A, Fornier M, Halpern JL, Tunick SJ, Huryn JM.
    Oncologist; 2008 Aug 28; 13(8):911-20. PubMed ID: 18695259
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.